WEGOVY .25 mg/.5mL

WEGOVY .25 mg/.5mL is a semaglutide injection solution used for weight management. This subcutaneous solution is designed to support individuals in their weight loss journey. Learn more about WEGOVY and its uses.

WEGOVY .25 mg/.5mL is primarily used for weight management in adults with obesity or overweight with at least one weight-related condition. Semaglutide, the active ingredient, works by regulating appetite and promoting feelings of fullness. This can help individuals reduce their caloric intake and achieve weight loss goals. WEGOVY is often used as part of a comprehensive weight management program that includes diet and exercise.

Common effects of WEGOVY .25 mg/.5mL may include nausea, diarrhea, constipation, injection site reactions, and fatigue. These effects are generally mild to moderate and may diminish over time as the body adjusts to the medication. It is important to monitor any persistent or severe side effects and consult a healthcare provider if necessary.

WEGOVY .25 mg/.5mL should be stored at controlled room temperature and protected from light. The solution should be clear and colorless; do not use if it appears discolored or contains particles. Always follow the prescribed dosage and administration instructions provided by a healthcare professional. Do not share this medication with others.

WEGOVY .25 mg/.5mL may interact with other medications, including those that affect blood sugar levels, such as insulin or other diabetes medications. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, alcohol consumption should be moderated as it may affect the efficacy and safety of WEGOVY.